TY - JOUR
T1 - The Prevalence of Chronic Diseases Among Older Chinese Adults in the Past 2 Decades
T2 - A Study Based on the Chinese Longitudinal Healthy Longevity Survey, 2002‒2022
AU - Cao, Kai
AU - Feng, Qiushi
AU - Tian, Wenxin
AU - Liu, Minhui
AU - Tang, Daisheng
AU - Feng, Taojin
AU - Sun, Xinyu
AU - Zeng, Yi
AU - Wang, Zhenglian
PY - 2025/12/1
Y1 - 2025/12/1
N2 - Objectives. To comprehensively analyze the prevalence of chronic diseases (hypertension, lung disease, diabetes, stroke, cancer, and heart disease) among older Chinese people. Methods. This study utilized data from 5 waves (2002, 2005, 2008, 2018, and 2022) of the Chinese Longitudinal Healthy Longevity Survey. We estimated prevalence rates using Poisson regression and Bayesian models from the DemoRates R-package and weighted according to the China population censuses. Results. The prevalence of most chronic diseases decreased in the first period and then increased substantially in the second period. Interestingly, the COVID-19 pandemic saw a decrease in the prevalence of most chronic diseases. Notably, hypertension was the most prevalent chronic condition among older adults, with a prevalence rate as high as 45.27% in 2018, and cancer exhibited the most significant increase in prevalence during the second period, with an average annual increase of 11.03%. Conclusions. Chronic disease prevalence among older Chinese adults exhibited dynamic and complex trends, influenced by socioeconomic factors, health care access, and public health emergencies. These findings highlight the importance of targeted interventions tailored to specific diseases, demographics, and regions. (Am J Public Health. 2025;115(12): 2053-2061. https://doi.org/10.2105/AJPH.2025.308245).
AB - Objectives. To comprehensively analyze the prevalence of chronic diseases (hypertension, lung disease, diabetes, stroke, cancer, and heart disease) among older Chinese people. Methods. This study utilized data from 5 waves (2002, 2005, 2008, 2018, and 2022) of the Chinese Longitudinal Healthy Longevity Survey. We estimated prevalence rates using Poisson regression and Bayesian models from the DemoRates R-package and weighted according to the China population censuses. Results. The prevalence of most chronic diseases decreased in the first period and then increased substantially in the second period. Interestingly, the COVID-19 pandemic saw a decrease in the prevalence of most chronic diseases. Notably, hypertension was the most prevalent chronic condition among older adults, with a prevalence rate as high as 45.27% in 2018, and cancer exhibited the most significant increase in prevalence during the second period, with an average annual increase of 11.03%. Conclusions. Chronic disease prevalence among older Chinese adults exhibited dynamic and complex trends, influenced by socioeconomic factors, health care access, and public health emergencies. These findings highlight the importance of targeted interventions tailored to specific diseases, demographics, and regions. (Am J Public Health. 2025;115(12): 2053-2061. https://doi.org/10.2105/AJPH.2025.308245).
UR - https://www.scopus.com/pages/publications/105021663561
U2 - 10.2105/AJPH.2025.308245
DO - 10.2105/AJPH.2025.308245
M3 - 文章
C2 - 40966574
AN - SCOPUS:105021663561
SN - 0090-0036
VL - 115
SP - 2053
EP - 2061
JO - American Journal of Public Health
JF - American Journal of Public Health
IS - 12
ER -